Literature DB >> 9780965

Prevalence of potentially reversible dementias and actual reversibility in a memory clinic cohort.

S Freter1, H Bergman, S Gold, H Chertkow, A M Clarfield.   

Abstract

BACKGROUND: Although clinics for the evaluation of cognitive dysfunction have typically emphasized the detection and treatment of the reversible causes of dementia, it remains unclear whether the treatment of such causes results in reversal of the dementia. Therefore, the appropriate work-up for dementia is in dispute.
METHODS: A chart review was performed with records from an urban tertiary care referral-based memory clinic. The records for 196 patients with dementia or suspected dementia, seen between October 1991 and December 1993, were examined to determine the prevalence of potentially reversible dementias and whether the cognitive dysfunction improved or resolved after treatment. Data abstracted from the medical charts included demographic information, medication use, presence of depression, and results of neuropsychological tests, blood work and neuroimaging. The clinical diagnosis, the response to treatment, if applicable, and the outcome (mean follow-up period 16 months) were analysed. The recommendations of the 1989 Canadian Consensus Conference on the Assessment of Dementia (CCCAD) on the use of CT were retrospectively applied in each case.
RESULTS: Of the 196 patients, 45 (23.0%) had a potentially reversible condition identified by history, physical examination, blood testing or CT; in only 7 (3.6% of the total) did treatment result in improvement or resolution of the dementia. These 7 patients had higher results for the Mini-Mental State examination (mean result 26) and exhibited only mild cognitive deficits. Potentially reversible lesions were found in the CT scans of 6 (3.1%) patients: 4 had normal-pressure hydrocephalus and 2 had a brain tumour. If the CCCAD recommendations had been followed, CT would have been performed in 76 (38.8%) of the patients, and 1 of the 6 patients with a lesion would have been missed.
INTERPRETATION: Both potential and actual reversibility of dementia was low in these memory clinic patients. The patients whose condition improved with intervention had early and milder cognitive deficits, which suggests that thorough evaluation of early memory loss is warranted.

Entities:  

Mesh:

Year:  1998        PMID: 9780965      PMCID: PMC1229695     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  37 in total

Review 1.  Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.

Authors:  G W Small; P V Rabins; P P Barry; N S Buckholtz; S T DeKosky; S H Ferris; S I Finkel; L P Gwyther; Z S Khachaturian; B D Lebowitz; T D McRae; J C Morris; F Oakley; L S Schneider; J E Streim; T Sunderland; L A Teri; L E Tune
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

Review 2.  Diagnosis and evaluation of dementia.

Authors:  J Corey-Bloom; L J Thal; D Galasko; M Folstein; D Drachman; M Raskind; D J Lanska
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

3.  Reversible dementia in elderly patients referred to a memory clinic.

Authors:  G J Walstra; S Teunisse; W A van Gool; H van Crevel
Journal:  J Neurol       Date:  1997-01       Impact factor: 4.849

4.  The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

Authors:  S L Rogers; L T Friedhoff
Journal:  Dementia       Date:  1996 Nov-Dec

5.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

Authors:  J E Graham; K Rockwood; B L Beattie; R Eastwood; S Gauthier; H Tuokko; I McDowell
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

6.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  M Sano; C Ernesto; R G Thomas; M R Klauber; K Schafer; M Grundman; P Woodbury; J Growdon; C W Cotman; E Pfeiffer; L S Schneider; L J Thal
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

Review 7.  Dementia: diagnosis and evaluation.

Authors:  K C Fleming; A C Adams; R C Petersen
Journal:  Mayo Clin Proc       Date:  1995-11       Impact factor: 7.616

8.  Reversible dementia: more than 10% or less than 1%? A quantitative review.

Authors:  M D Weytingh; P M Bossuyt; H van Crevel
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

9.  Unsuspected subdural hematoma as a differential diagnosis in elderly patients.

Authors:  J Velasco; M Head; E Farlin; S Lippmann
Journal:  South Med J       Date:  1995-09       Impact factor: 0.954

10.  The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities.

Authors:  R Carmel; P S Gott; C H Waters; K Cairo; R Green; W Bondareff; C M DeGiorgio; J L Cummings; D W Jacobsen; G Buckwalter
Journal:  Eur J Haematol       Date:  1995-04       Impact factor: 2.997

View more
  13 in total

Review 1.  Canadian Consensus Conference on Dementia: a physician's guide to using the recommendations.

Authors:  C J Patterson; S Gauthier; H Bergman; C A Cohen; J W Feightner; H Feldman; D B Hogan
Journal:  CMAJ       Date:  1999-06-15       Impact factor: 8.262

2.  The rural older adult memory (ROAM) study: a practice-based intervention to improve dementia screening and diagnosis.

Authors:  Linda Boise; Elizabeth Eckstrom; Lyle Fagnan; Anne King; Monica Goubaud; David I Buckley; Cynthia Morris
Journal:  J Am Board Fam Med       Date:  2010 Jul-Aug       Impact factor: 2.657

Review 3.  Memory clinics.

Authors:  D Jolley; S M Benbow; M Grizzell
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

4.  Management of dementia by family physicians in academic settings.

Authors:  Nicholas J G Pimlott; Karen Siegel; Malini Persaud; Susan Slaughter; Carole Cohen; Gary Hollingworth; Sandy Cummings; Neil Drummond; William Dalziel; James Sylvius; Dorothy Pringle; Tex Eliasziw
Journal:  Can Fam Physician       Date:  2006-09       Impact factor: 3.275

5.  Guidelines for the treatment of Alzheimer's disease from the Italian Association of Psychogeriatrics.

Authors:  Carlo Caltagirone; Angelo Bianchetti; Monica Di Luca; Patrizia Mecocci; Alessandro Padovani; Elvezio Pirfo; Pierluigi Scapicchio; Umberto Senin; Marco Trabucchi; Massimo Musicco
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

6.  Use of aggressive medical treatments near the end of life: differences between patients with and without dementia.

Authors:  Samuel S Richardson; Greer Sullivan; Ariel Hill; Wei Yu
Journal:  Health Serv Res       Date:  2007-02       Impact factor: 3.402

7.  Frequency of dementia syndromes with a potentially treatable cause in geriatric in-patients: analysis of a 1-year interval.

Authors:  Marija Djukic; Dirk Wedekind; Almuth Franz; Melanie Gremke; Roland Nau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-02-26       Impact factor: 5.270

Review 8.  Diagnosis and treatment of dementia: 2. Diagnosis.

Authors:  Howard H Feldman; Claudia Jacova; Alain Robillard; Angeles Garcia; Tiffany Chow; Michael Borrie; Hyman M Schipper; Mervin Blair; Andrew Kertesz; Howard Chertkow
Journal:  CMAJ       Date:  2008-03-25       Impact factor: 8.262

Review 9.  The appropriate use of neuroimaging in the diagnostic work-up of dementia: an economic literature review and cost-effectiveness analysis.

Authors:  S L Bermingham
Journal:  Ont Health Technol Assess Ser       Date:  2014-02-01

Review 10.  The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2014-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.